Suggestions
Drew Jones
Senior Clinical Consultant (SSI Strategy )
Drew Jones, MD, MPH, MBA, is a distinguished medical professional with over 20 years of extensive experience in Life Sciences, particularly within Clinical Development and Medical Affairs. His expertise spans a diverse range of medical fields including Neurology, Renal, Gastrointestinal conditions, Rare Diseases, and Gene Therapy. Additionally, Dr. Jones possesses comprehensive knowledge in Medical Devices, Business Development, Asset Evaluation, Strategic Planning, and addressing Health Disparities, positioning him as a thought leader in various healthcare sectors.
Dr. Jones’s educational background is as impressive as his career. He completed his MD at The Brody School of Medicine at East Carolina University, following which he pursued further training with a residency in Anesthesiology at Howard University Hospital and an internship in Internal Medicine at George Washington University Medical Center. His dedication to learning extended beyond medicine; he earned an MBA in Business Administration from the University of Maryland Global Campus and a Master of Public Health (MPH) in Nutrition from the University of North Carolina at Chapel Hill. His academic journey began with a Bachelor of Arts in History from Duke University, where he cultivated critical thinking and analytical skills that have served him well throughout his career.
During his professional journey, Drew Jones has held various significant positions at renowned organizations, contributing to advancements in Clinical Development and Medical Affairs. Currently, he serves as a Senior Clinical Consultant at SSI Strategy, where he utilizes his extensive knowledge to guide clinical development efforts and strategic planning for medical devices. Prior to this role, he was the Vice President of Clinical Development at Krystal Biotech, Inc., where he played a vital role in driving innovative therapies forward. Dr. Jones has also made impactful contributions at Novartis Gene Therapies as the Senior Medical Director and held similar executive roles at Takeda Development Center Americas, Inc., Baxter International Inc., and multiple others. His leadership in various clinical settings has been transformative, leading to innovative therapeutic developments that impact patient care across the globe.
Dr. Jones’s engagement extends to his governance roles, including a position on the Board of Directors as a co-finance chairman at WeCare Health Plans, Inc., where he contributes to strategic financial decisions that enhance healthcare accessibility and equity. His background as an Independent Clinical Consultant has allowed him to provide invaluable insights for several organizations such as Intermune and Theravance, showcasing his ability to adapt his expertise across different contexts. With a track record in clinical development and a deep understanding of both the scientific and business aspects of healthcare, Drew Jones stands out as a leader committed to improving medical outcomes and addressing health disparities.
